Drug and Alcohol Dependence
Volume 94, Issue 1 , Pages 221-233 , 1 April 2008

Racial and ethnic changes in heroin injection in the United States: Implications for the HIV/AIDS epidemic

Received 30 August 2007 ,Revised 25 November 2007 ,Accepted 26 November 2007.

References 

  1. Adair EB, Craddock SG, Miller HG, Turner CF. Assessing consistency of responses to questions on cocaine use. Addiction. 1995;90:1497–1502
  2. Adair EB, Craddock SG, Miller HG, Turner CF. Quality of treatment data. Reliability over time of self-reports given by clients in treatment for substance abuse. J. Subst. Abuse. Treat. 1996;13:145–149
  3. Agar M, Reisinger HS. A heroin epidemic at the intersection of histories: the 1960s epidemic among African Americans in Baltimore. Med. Anthropol. 2002;21:115–156
  4. Agar MH, Reisinger HS. Explaining drug use trends: suburban heroin use in Baltimore County. In:  Springer A,  Uhl A editor. Illicit Drugs: Patterns of Use—Patterns of Response. Innsbruck: STUDIENVerlag; 2000;p. 143–165
  5. Agar MH, Reisinger HS. Open marginality: heroin epidemics in different groups. J. Drug Issues. 2001;31:729–746
  6. Armstrong GL. Injection drug users in the United States, 1979–2002: an aging population. Arch. Intern. Med. 2007;167:166–173
  7. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 2006;144:705–714
  8. Bailey SL, Ouellet LJ, Mackesy-Amiti ME, Golub ET, Hagan H, Hudson S, et al. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young injection drug users in 5 U.S. cities. Drug Alcohol Depend. 2007;91S:S18–S29
  9. In:  Ball JC,  Chambers CD editor. The Epidemiology of Opiate Addiction in the United States. Springfield, IL: Charles C. Thomas; 1970;
  10. Ball JC, Cottrell ES. Admissions of narcotic drug addicts to public health service hospitals, 1935–63. Public Health Rep. 1965;80:471–475
  11. Berk RA, Western B, Weiss RE. Statistical inference for apparent populations. Sociol. Methodol. 1995;25:421–458
  12. Bourgois P, Martinez A, Kral A, Edlin BR, Schonberg J, Ciccarone D. Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. PloS. Med. 2006;3:e452
  13. Boyle JM, Brunswick AF. What happened in Harlem? Analysis of a decline in heroin use among a generation unit of urban Black youth. J. Drug Issues. 1980;10:109–130
  14. Brecher EM. Licit and Illicit Drugs. Boston, MA: Little, Brown and Company; 1972;
  15. CDC, 2006. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveill Rep., vol 17. US Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Atlanta.
  16. CDC . Epidemiology of HIV/AIDS—United States, 1981–2006. MMWR Morb. Mortal Wkly. Rep. 2006;55:589–592
  17. Chitwood DD, Comerford M, Weatherby NL. The initiation of the use of heroin in the age of crack. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage; 1998;p. 51–76
  18. Clayton RR, Voss HL. Young men and drugs in Manhattan: a causal analysis. NIDA Res. Monogr. 1981;39:1–187
  19. Community Epidemiology Work Group, 1999. Epidemiologic Trends in Drug Abuse: vol. 1, Executive Summary, December 1998. NIH Pub. No. 99-4526. National Institute on Drug Abuse, Rockville, MD.
  20. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology. 2006;131:470–477
  21. Cooper H, Friedman SR, Tempalski B, Friedman R, Keem M. Racial/ethnic disparities in injection drug use in large US metropolitan areas. Ann. Epidemiol. 2005;15:326–334
  22. Courtwright DT. Dark Paradise: Opiate Addiction in America Before 1940. Cambridge, MA: Harvard University Press; 1982;
  23. Dai B. Opium Addiction in Chicago. Montclair, NJ: Patterson Smith; 1970;
  24. Des Jarlais DC, Friedman SR, Perlis T, Chapman TF, Sotheran JL, Paone D, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1999;20:67–72
  25. DuPont RL, Greene MH. The dynamics of a heroin addiction epidemic. Science. 1973;181:716–722
  26. Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J. Urban Health. 2003;80:137–146
  27. Frank B. An overview of heroin trends in New York City: past, present and future. Mt. Sinai. J. Med. 2000;67:340–346
  28. Friedman SR, Chapman TF, Perlis TE, Rockwell R, Paone D, Sotheran JL, et al. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991–1996. J. Acquir. Immune. Defic. Syndr. 1999;22:83–91
  29. Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 2002;66:189–198
  30. Fuller CM, Vlahov D, Arria AM, Ompad DC, Garfein R, Strathdee SA. Factors associated with adolescent initiation of injection drug use. Public Health Rep. 2001;116:136–145
  31. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson K, Vlahov D. Prevalence and incidence of hepatitis C infection among young adult injection drug users. J. Acquir. Immune. Defic. Syndr. 1998;18(Suppl. 1):S11–S19
  32. Garfein RS, Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007;21:1923–1932
  33. Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007;91S:S4–S17
  34. General Accounting Office (GAO), 1993. Needle Exchange Programs: Research Suggests a Promising AIDS Strategy. US Government Printing Office, Washington DC.
  35. Gfroerer J, Brodsky M. The incidence of illicit drug use in the United States, 1962–1989. Br. J. Addict. 1992;87:1345–1351
  36. Ghanem KG, Hutton HE, Zenilman JM, Zimba R, Erbelding EJ. Audio computer assisted self-interview and face to face interview modes in assessing response bias among STD clinic patients. Sex Transm. Infect. 2005;81:421–425
  37. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329–1341
  38. Golub AL, Johnson BD. Cohort changes in illegal drug use among arrestees in Manhattan: from the Heroin Injection Generation to the Blunts Generation. Subst. Use Misuse. 1999;34:1733–1763
  39. Havens JR, Sherman SG, Sapun M, Strathdee SA. Prevalence and correlates of suicidal ideation among young injection vs. noninjection drug users. Subst. Use Misuse. 2006;41:245–254
  40. Havens JR, Strathdee SA, Fuller CM, Ikeda R, Friedman SR, Des Jarlais DC, et al. Correlates of attempted suicide among young injection drug users in a multi-site cohort. Drug Alcohol Depend. 2004;75:261–269
  41. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Social Problems. 1997;44:174–199
  42. Hughes PH, Barker NW, Crawford GA, Jaffe JH. The natural history of a heroin epidemic. Am. J. Public Health. 1972;62:995–1001
  43. Hughes PH, Rieche O. Heroin epidemics revisited. Epidemiol. Rev. 1995;17:66–73
  44. Hunt LB, Chambers CD. The Heroin Epidemics. A study of Heroin Use in the United States, 1965–1975. New York, NY: Spectrum Publications, Inc.; 1976;
  45. Johnson BD, Golub A. Generational trends in heroin use and injection in New York City. In:  Musto DF editors. One Hundred Years of Heroin. Westport, CT: Auburn House of Greenwood Publishing Group, Inc.; 2002;p. 92–128
  46. Johnson BD, Thomas G, Golub A. Trends in heroin use among Manhattan arrestees from the heroin and crack eras. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage; 1998;p. 109–130
  47. Johnson BD, Williams T, Kojo AD, Sanabria H. Drug abuse in the inner city: impact on hard-drug users and the community. In:  Tonry M,  Wilson JQ editor. Drug and Crime (Crime and Justice: A Review of Research, vol. 13). Chicago: University of Chicago Press; 1990;p. 9–67
  48. Kelley MS, Chitwood DD. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?. Soc. Sci. Med. 2004;58:2083–2092
  49. Kieffer KM, Thompson B. Interpreting statistical significance test results: a proposed new “what if” method. In: Paper Presented at: Annual Meeting of the Mid-South Educational Research Association. Point Clear, AL, November 19. 1999;
  50. Kinlock TW, Hanlon TE, Nurco DN. Heroin use in the United States: history and present developments. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack Cocaine. Thousand Oaks, CA: Sage; 1998;p. 1–30
  51. Kral AH, Lorvick J, Edlin BR. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune. Defic. Syndr. 2000;24:162–167
  52. Lankenau SE, Sanders B, Bloom JJ, Hathazi D, Alarcon E, Tortu S, et al. First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend. 2007;87:183–193
  53. Lansky A, Abdul-Quader AS, Cribbin M, Hall T, Finlayson TJ, Garfein RS, et al. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(Suppl. 1):48–55
  54. Layden-Almer JE, Ribeiro RM, Wiley T, Perelson AS, Layden TJ. Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin. Hepatology. 2003;37:1343–1350
  55. Lurie P, Reingold AL, Bowser B, Chen D, Foley J, Guydish J, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco: University of California, Berkeley, School of Public Health; The Institute for Health Studies; 1993;
  56. Nainan OV, Alter MJ, Kruszon-Moran D, Gao FX, Xia G, McQuillan G, et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology. 2006;131:478–484
  57. National Academy of Sciences . Preventing HIV Infection among Injecting Drug Users in High Risk Countries: An Assessment of the Evidence. Washington, DC: National Academies Press; 2006;
  58. NDIC, 2006. National Drug Threat Assessment 2007. Pub. No. 2006-Q0317-003. US Department of Justice, National Drug Intelligence Center (NDIC), Johnstown, PA.
  59. Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J. Acquir. Immune. Defic. Syndr. 2006;41:493–503
  60. Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Ildefonso G, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction. 2001;96:847–860
  61. In:  Normand J,  Vlahov D,  Moses LE editor. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995;
  62. Novelli LA, Sherman SG, Havens JR, Strathdee SA, Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend. 2005;77:303–309
  63. O’Donnell JA, Jones JP. Diffusion of the intravenous technique among narcotic addicts in the United States. J. Health Soc. Behav. 1968;9:120–130
  64. O’Donnell JA, Voss HL, Clayton RR, Slatin GT, Room RG. Young men and drugs-a nationwide survey. NIDA Res. Monogr. 1976;1–144pp. i–xiv
  65. Ouellet LJ, Jimenez AD, Johnson WA, Wiebel WW. Heroin again: new users of heroin in Chicago. In: Paper Presented at: Annual Meeting of the Society for the Study of Social Problems. Miami Beach, FL August 11–13. 1993;
  66. Patton MQ. Qualitative Evaluation and Research Methods. second ed.. Newbury Park, CA: Sage; 1990;
  67. Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF. Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs. Addiction. 2004;99:885–896
  68. Pescor MJ. A statistical analysis of the clinical records of hospitalized drug addicts. Public Health Rep. 1938;(Suppl. No. 143):1–30
  69. Rittenhouse JD. The epidemiology of heroin and other narcotics. NIDA Res. Monogr. 1977;16:1–247pp. i–xii
  70. Schiller NG. What's wrong with this picture? The hegemonic construction of culture in AIDS research in the United States. Med. Anthropol. Q. 1992;6:237–254
  71. Schoener EP, Hopper JA, Pierre JD. Injection drug use in North America. Infect. Dis. Clin. North Am. 2002;16:535–551
  72. Sherman SG, Fuller CM, Shah N, Ompad DV, Vlahov D, Strathdee SA. Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early intervention. J. Psychoactive Drugs. 2005;37:437–443
  73. Spunt B. The current New York City heroin scene. Subst. Use Misuse. 2003;38:1539–1549
  74. Strang J, Griffiths P, Gossop M. Heroin in the United Kingdom: different forms, different origins, and the relationship to different routes of administration. Drug Alcohol Rev. 1997;16:329–337
  75. Substance Abuse and Mental Health Service Administration (SAMHSA), 1999. Treatment Episode Data Set (TEDS): 1992–1997. DASIS Series S-7. DHHS Pub. No. (SMA) 99–3324. SAMHSA, Office of Applied Studies, Rockville, MD.
  76. Substance Abuse and Mental Health Service Administration (SAMHSA), 2003. The DASIS report: new heroin users admitted to treatment: 1992–2000. SAMHSA, Office of Applied Studies, Rockville, MD.
  77. Substance Abuse and Mental Health Service Administration (SAMHSA), 2006. Treatment Episode Data Set (TEDS). SAMHSA, Office of Applied Studies, Rockville, MD. Available at: http://www.oas.samhsa.gov/dasis.htm#teds2 (accessed May 2, 2006).
  78. Substance Abuse and Mental Health Service Administration (SAMHSA), 2007. The NSDUH report: demographic and geographic variations in injection drug use. SAMHSA, Office of Applied Studies. Rockville, MD.
  79. Terry CE, Pellens M. The extent of chronic opiate use in the United States prior to 1921. In:  Ball JC,  Chambers CD editor. The Epidemiology of Opiate Addiction in the United States. Springfield, IL: Charles C. Thomas; 1970;p. 36–67
  80. The Ohio Substance Abuse Monitoring Network, 2006. Young heroin users & treatment experiences in Ohio: a targeted response initiative. Ohio Department of Alcohol and Drug Addiction Services, Columbus, OH.
  81. Thorpe LE, Bailey SL, Huo D, Monterroso ER, Ouellet LJ. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997–1999). J. Acquir. Immune. Defic. Syndr. 2001;27:71–78
  82. Turner CF, Hubbard RL. Quality of alcohol use histories collected at intake to substance user treatment. Int. J. Addict. 1995;30:963–989
  83. US Census Bureau, 2005. American Community Survey. Available at: http://factfinder.census.gov (accessed December 8, 2006).
  84. US Census Bureau, 2000. US Census 2000. Available at: http://www.census.gov/main/www/cen2000 (accessed October 22, 2007).
  85. Vlahov D, Anthony JC, Muñoz A, Margolick J, Nelson KE, Celentano DD, et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J. Drug Issues. 1991;21:759–776
  86. Wodak A, Cooney A. Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users. Geneva: World Health Organization; 2005;

PII: S0376-8716(07)00492-9

doi: 10.1016/j.drugalcdep.2007.11.020

Drug and Alcohol Dependence
Volume 94, Issue 1 , Pages 221-233 , 1 April 2008

Article Tools

* Image Usage & Resolution